Lv1
40 积分 2025-04-17 加入
Low-intensity inflammation as a manifestation of comorbidity and a factor in the unfavorable clinical course of heart failure with preserved ejection fraction
4个月前
已关闭
Abstract 11983: Biomarker Profile of Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction or Reduced Ejection Fraction: Insights From the ARISTOTLE Trial
4个月前
已关闭
Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction
4个月前
已完结
Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction
4个月前
已完结
Impact of MASLD and MetALD on clinical outcomes: A meta‐analysis of preliminary evidence
4个月前
已完结
Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD
5个月前
已完结
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
8个月前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
8个月前
已完结
皖公网安备34019202002308
